Diagnosis of Hepatocellular Carcinoma Using C-11 Choline PET/CT: Comparison with F-18 FDG, Contrast-Enhanced MRI and MDCT |
Chotipanich, Chanisa
(National Cyclotron and PET Centre, Chulabhorn Hospital)
Kunawudhi, Anchisa (National Cyclotron and PET Centre, Chulabhorn Hospital) Promteangtrong, Chetsadaporn (National Cyclotron and PET Centre, Chulabhorn Hospital) Tungsuppawattanakit, Puntira (Medical Imaging Unit, Chulabhorn Hospital) Sricharunrat, Thaniya (Pathology Unit, Chulabhorn Hospital) Wongsa, Paramest (National Cyclotron and PET Centre, Chulabhorn Hospital) |
1 | Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD (2005). Management of hepatocellular carcinoma. Hepatol, 42, 1208-36. DOI |
2 | Castilla-Lievre MA, Franco D, Gervais P, et al (2016). Diagnostic value of combining C-choline and F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging, 43, 852-9. DOI |
3 | Fartoux L, Balogova S, Nataf V, et al (2012). A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection. Nucl Med Commun, 33, 757-65. DOI |
4 | Glunde K, Bhujwalla ZM, Ronen SM (2011). Choline metabolism in malignant transformation. Nat Rev Cancer, 11, 835-48. DOI |
5 | Hara T, Kosaka N, Shinoura N, et al (1997). PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med, 38, 842-7. |
6 | Iwata Y, Shiomi S, Sasaki N, et al (2000). Clinical usefulness of positron emission tomography with fluorine-18- fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med, 14, 121-6. DOI |
7 | Jeng LB, Changlai SP, Shen YY, et al (2003). Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterol, 50, 2154-6. |
8 | Kanwal F, Befeler A, Chari RS, et al (2012). Potentially curative treatment in patients with hepatocellular cancer--results from the liver cancer research network. Aliment Pharmacol Ther, 36, 257-65. DOI |
9 | Khan MA, Combs CS, Brunt EM, et al (2000). Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol, 32, 792-7. |
10 | Kelloff GJ, Hoffman JM, Johnson B, et al (2005). Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res, 11, 2785-808. DOI |
11 | Kolthammer JA, Corn DJ, Tenley N, et al (2011). PET imaging of hepatocellular carcinoma with 18F-fluoroethylcholine and 11C-choline. Eur J Nucl Med Mol Imaging, 38, 1248-56. DOI |
12 | Kuang Y, Salem N, Corn DJ, et al (2010). Transport and metabolism of radiolabeled choline in hepatocellular carcinoma. Mol Pharm, 7, 2077-92. DOI |
13 | Talbot JN, Fartoux L, Balogova S, et al (2010). Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med, 51, 1699-706. DOI |
14 | Lin WY, Tsai SC, Hung GU (2005). Value of delayed 18F-FDGPET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun, 26, 315-21. DOI |
15 | Lopci E, Torzilli G, Poretti D, et al (2015). Diagnostic accuracy of (1)(1)C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging, 42, 1399-407. DOI |
16 | Picchio M, Castellucci P (2012). Clinical indications of C-choline PET/CT in prostate cancer patients with biochemical relapse. Theranostics, 2, 313-7. DOI |
17 | Wu HB, Wang QS, Li BY, et al (2011). F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma. Clin Nucl Med, 36, 1092-7. DOI |
18 | Talbot JN, Gutman F, Fartoux L, et al (2006). PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging, 33, 1285-9. DOI |
19 | Teefey SA, Hildeboldt CC, Dehdashti F, et al (2003). Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiol, 226, 533-42. DOI |
20 | Wolfort RM, Papillion PW, Turnage RH, et al (2010). Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Int Surg, 95, 67-75. |
21 | Yamamoto Y, Nishiyama Y, Kameyama R, et al (2008). Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET. J Nucl Med, 49, 1245-8. DOI |
22 | Bolog N, Andreisek G, Oancea I, et al (2011). CT and MR imaging of hepatocellular carcinoma. J Gastrointestin Liver Dis, 20, 181-9. |
23 | Bieze M, Klumpen HJ, Verheij J, et al (2014). Diagnostic accuracy of (18) F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma. Hepatol, 59, 996-1006. DOI |